Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis
In patients with gastric cancer (GC), circulating microRNA-21 (miR-21) is overexpressed and may serve as a diagnostic biomarker. In the present study, it was hypothesized that the serum miR-21 expression levels were associated with prognosis in the patients with GC. The expression levels of serum mi...
Main Authors: | SONG, JIANNING, BAI, ZHIGANG, ZHANG, JUN, MENG, HUA, CAI, JUN, DENG, WEI, BI, JINTAO, MA, XUEMEI, ZHANG, ZHONGTAO |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834305/ |
Similar Items
-
Prognostic Role of MicroRNA-21 in Gastric Cancer: A Meta-Analysis
by: Wang, Zhenqiang, et al.
Published: (2014) -
Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
by: Li, Jun, et al.
Published: (2016) -
Reduced NKX2.1 Expression Predicts Poor Prognosis of Gastric Carcinoma
by: Zhao, Bai-Wei, et al.
Published: (2014) -
Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
by: Han, Shiwei, et al.
Published: (2016) -
MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression
by: Liu, Jun, et al.
Published: (2015)